Premium
P1–439: NO chimera drugs provide reversal of cognition deficits in animal models: GT 1061 an investigational new drug for Alzheimer's
Author(s) -
Thatcher Gregory R.J.,
Bennett Brian M.,
Reynolds James N.,
Sutherland Robert M.,
Abdul-Hay Samer
Publication year - 2006
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2006.05.818
Subject(s) - neuroscience , cognition , saporin , cholinergic , psychology , forebrain , acetylcholine , hippocampal formation , hippocampus , medicine , pharmacology , central nervous system , immunotoxin , antibody , immunology , monoclonal antibody
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom